Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB – Get Free Report)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $6.82 and last traded at $6.82, with a volume of 0 shares changing hands. The stock had previously closed at $0.68.
Lakeshore Biopharma Stock Up 900.0 %
The company has a current ratio of 1.13, a quick ratio of 0.87 and a debt-to-equity ratio of 0.17. The stock’s fifty day moving average price is $0.52.
About Lakeshore Biopharma
LakeShore Biopharma Co, Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.
Featured Articles
- Five stocks we like better than Lakeshore Biopharma
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Lennar Stock Could Be the Best Play in the Housing Market
- NYSE Stocks Give Investors a Variety of Quality Options
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Are the U.K. Market Holidays? How to Invest and Trade
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
